ZA781398B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA781398B
ZA781398B ZA00781398A ZA781398A ZA781398B ZA 781398 B ZA781398 B ZA 781398B ZA 00781398 A ZA00781398 A ZA 00781398A ZA 781398 A ZA781398 A ZA 781398A ZA 781398 B ZA781398 B ZA 781398B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ZA00781398A
Other languages
English (en)
Inventor
R Todd
G Fryers
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of ZA781398B publication Critical patent/ZA781398B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA00781398A 1977-03-10 1978-03-09 Pharmaceutical compositions ZA781398B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB10133/77A GB1566609A (en) 1977-03-10 1977-03-10 Pharmaceutical compositions containing cholestyramine and alginic acid

Publications (1)

Publication Number Publication Date
ZA781398B true ZA781398B (en) 1979-02-28

Family

ID=9962124

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00781398A ZA781398B (en) 1977-03-10 1978-03-09 Pharmaceutical compositions

Country Status (14)

Country Link
US (1) US4172120A (fr)
JP (1) JPS53113007A (fr)
AU (1) AU518596B2 (fr)
BE (1) BE864726A (fr)
CA (1) CA1087986A (fr)
CH (1) CH647949A5 (fr)
DE (1) DE2810250A1 (fr)
FR (1) FR2382893A1 (fr)
GB (1) GB1566609A (fr)
IE (1) IE46479B1 (fr)
IT (1) IT7867510A0 (fr)
NL (1) NL7802588A (fr)
NZ (1) NZ186656A (fr)
ZA (1) ZA781398B (fr)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439419A (en) * 1980-02-20 1984-03-27 The Upjohn Company Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin
US4414198A (en) * 1982-04-23 1983-11-08 Joseph Michaelson Rapidly disintegrable tablet composition and method
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
EP0250572A1 (fr) * 1986-01-03 1988-01-07 The University Of Melbourne Composition contre les reflux gastro-oesophagiens
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
IT1190349B (it) * 1986-06-16 1988-02-16 Prodotti Formenti Srl Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
US5167965A (en) * 1987-02-09 1992-12-01 The Dow Chemical Company Palatable cholestyramine granules, tablets and methods for preparation thereof
US4837255A (en) * 1987-03-10 1989-06-06 Ciba-Geigy Corporation Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin
US5910317A (en) * 1988-01-11 1999-06-08 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
DE3808191C2 (de) * 1988-03-11 1998-08-06 Astra Chem Gmbh Colestyramin enthaltende pharmazeutische Zusammensetzung
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
CA2002492A1 (fr) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Compose pharmaceutique contenant une resine echangeuse d'ions
IL95574A (en) 1989-09-09 1994-11-11 Knoll Ag Colestyramine preparation
DE3935550A1 (de) * 1989-10-25 1991-05-02 Pharmatrans Sanaq Ag Kaubare oder lutschbare arzneiform, verfahren zu ihrer herstellung und ihre verwendung
FR2664499B1 (fr) * 1990-07-16 1994-11-04 Jacques Dubois Nouvelles formes pharmaceutiques, leur procede de preparation et leurs applications.
EP0484106A1 (fr) * 1990-11-01 1992-05-06 Merck & Co. Inc. Compositions à libération contrôlée
US5166137A (en) * 1991-03-27 1992-11-24 Nobipols Forskningsstiftelse Guluronic acid polymers and use of same for inhibition of cytokine production
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
US5422101A (en) * 1993-05-14 1995-06-06 The Procter & Gamble Company Cholesterol lowering drink mix compositions
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
JP2001522368A (ja) * 1997-04-30 2001-11-13 レキット アンド コールマン プロダクツ リミテッド 流動性アルギン酸塩組成物
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB0012094D0 (en) * 2000-05-19 2000-07-12 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
CA2622693C (fr) * 2005-09-15 2015-05-05 Genzyme Corporation Formulation en sachet pour des polymeres amines
NZ598728A (en) * 2006-12-22 2013-09-27 Ironwood Pharmaceuticals Inc Compositions comprising bile acid sequestrants for treating esophageal disorders
WO2009158625A2 (fr) * 2008-06-26 2009-12-30 Ironwood Pharmaceuticals, Inc. Compositions et procédés de traitement ou de prévention des troubles gastro-intestinaux et des troubles respiratoires liés à gerd
ES2651948T3 (es) * 2008-10-02 2018-01-30 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Administración de un polímero adsorbente para el tratamiento de la inflamación sistémica
US9186409B2 (en) 2010-04-23 2015-11-17 S-Biotek Holidng Aps Solid pharmaceutical composition for neutralizing stomach acid
ES2586931T3 (es) 2010-11-04 2016-10-19 Albireo Ab Inhibidores de IBAT para el tratamiento de enfermedades hepáticas
RU2619215C2 (ru) 2010-11-08 2017-05-12 Альбирео Аб Фармацевтическая комбинация, включающая ibat-ингибитор и связующее желчной кислоты
BR112014010223B8 (pt) 2011-10-28 2021-02-23 Lumena Pharmaceuticals Llc uso de uma composição compreendendo inibidores de reciclagem de ácido de bílis e forma de dosagem pediátrica
KR102051031B1 (ko) 2011-10-28 2019-12-02 루메나 파마수티컬즈, 인코포레이티드 고담혈증 및 담즙 정체성 간 질환 치료용 담즙산 재순환 억제제
FR2994387B1 (fr) * 2012-08-13 2016-07-29 Basf Beauty Care Solutions France Sas Ingredient hydratant cosmetique ou pharmaceutique
KR20160003664A (ko) 2013-03-15 2016-01-11 루메나 파마수티컬즈, 인코포레이티드 바렛 식도 및 위식도 역류 질환 치료용 담즙산 재순환 억제제
EP2968230A2 (fr) 2013-03-15 2016-01-20 Lumena Pharmaceuticals, Inc. Inhibiteurs du recyclage de l'acide biliaire pour le traitement de l'angiocholite sclérosante primaire et de la maladie inflammatoire de l'intestin
US20160129025A1 (en) * 2013-07-15 2016-05-12 Chengzhi Life Science., Ltd. Anti-fatigue composition and use thereof
CN106659726A (zh) 2014-06-25 2017-05-10 Ea制药株式会社 固体制剂及其着色防止或着色减少方法
EP3012252A1 (fr) 2014-10-24 2016-04-27 Ferring BV Formes crystallines d'Elobixibat
US10245284B2 (en) 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration
EP3413878B1 (fr) 2016-02-09 2021-04-14 Albireo AB Formulation orale de cholestyramine et utilisation associée
EP3413875B1 (fr) 2016-02-09 2020-01-29 Albireo AB Pastilles de cholestyramine et procédés de préparation associés
EP3413877B1 (fr) 2016-02-09 2021-04-07 Albireo AB Formulation orale de cholestyramine et utilisation associée
JP2020530448A (ja) 2017-08-09 2020-10-22 アルビレオ・アクチボラグ コレスチラミン顆粒、経口コレスチラミン製剤、及びそれらの使用
JP7391048B2 (ja) 2018-06-05 2023-12-04 アルビレオ・アクチボラグ ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
MX2020013839A (es) 2018-06-20 2021-03-25 Albireo Ab Formulacion farmaceutica de odevixibat.
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
CA3129826A1 (fr) 2019-02-12 2020-08-20 Mirum Pharmaceuticals, Inc. Procedes de traitement de la cholestase

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK106457C (da) 1962-01-23 1967-02-06 Ernst Helmer Hagstam Røntgenkontrastmiddel med lille massefylde og fremgangsmåde til dets fremstilling.
DE1195213B (de) * 1963-06-12 1965-06-16 Dynamit Nobel Ag Zuendladung fuer zuendunwillige Sprengstoffe
US3499960A (en) * 1965-01-25 1970-03-10 Merck & Co Inc Palatable coated particles of an anion exchange resin
US3769399A (en) * 1971-03-05 1973-10-30 L Hagerman Intestinal bile acid binding process and compositions
US3974272A (en) * 1972-09-01 1976-08-10 Merck & Co., Inc. Palatable cholestyramine coacervate compositions
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions

Also Published As

Publication number Publication date
CH647949A5 (de) 1985-02-28
IE780486L (en) 1978-09-10
NZ186656A (en) 1979-06-19
FR2382893B1 (fr) 1981-07-10
DE2810250A1 (de) 1978-09-14
AU3396978A (en) 1979-09-13
GB1566609A (en) 1980-05-08
IT7867510A0 (it) 1978-03-09
BE864726A (fr) 1978-09-11
JPS53113007A (en) 1978-10-03
NL7802588A (nl) 1978-09-12
FR2382893A1 (fr) 1978-10-06
AU518596B2 (en) 1981-10-08
CA1087986A (fr) 1980-10-21
US4172120A (en) 1979-10-23
IE46479B1 (en) 1983-06-29

Similar Documents

Publication Publication Date Title
ZA785682B (en) Pharmaceutical compositions
GB2003028B (en) Pharmaceutical compositions
JPS53113007A (en) Pharmaceutical composition
JPS53109934A (en) Pharmaceutical composition
JPS5484022A (en) Pharmaceutical composition
JPS5449333A (en) Pharmaceutical composition
JPS53133637A (en) Pharmaceutical composition
PH15193A (en) Pharmaceutical composition
GB2008403B (en) Pharmaceutical compositions
ZM1878A1 (en) Pharmaceutical compositions
GB2021409B (en) Pharmaceutical composition
GB2002229B (en) Pharmaceutical composition
ZA784470B (en) Pharmaceutical compositions including antithormbotic compositions
JPS5394038A (en) Pharmaceutical composition
NZ186334A (en) Oxadiazolopyrimidines:pharmaceutical compositions
IL54220A (en) Pharmaceutical compositions comprising trans-broparestrol
JPS5486607A (en) Solid pharmaceutical composition
ZA78387B (en) Pharmaceutical compositions
GB2008408B (en) Pharmaceutical compositions
ZA7812B (en) Pharmaceutical compositions
JPS545045A (en) Pharmaceutical composition
NZ188040A (en) 1-phenylethanolamine derivatives pharmaceutical compositions
GB1556851A (en) Pharmaceutical compositions
ZA782736B (en) Pharmaceutical compositions
JPS542338A (en) Pharmaceutical composition